Article
COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies.
Breast cancer research and treatment - 1 Aug 2010
Ding Haixia, Fu Yuanyuan, Chen Weixian, Wang Zhanwei
Abstract excerpt
The Catechol-O-methyltransferase (COMT) plays an important role in the development of breast cancer. Many previous epidemiologic studies explored the association of COMT Val158Met polymorphism with breast cancer susceptibility. However, the results were inconsistent. We therefore performed a meta-analysis of 26 published studies including 16,693 breast cancer patients and 18,261 healthy controls. Crude odds...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
